This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Cardiology Remove Doctors Remove Insulin Related Topics
Clinical Development Gene Development Research Clinical Trials Medicine Trials Drugs Doctor Production More Related Topics >
article thumbnail

Diabetes Boosts Odds for Heart Trouble 10-fold in Younger Women

The Pharma Data

JANUARY 21, 2021

Both of those factors had weaker associations with heart disease onset in women younger than 55 than lipoprotein insulin resistance (LPIR,) a newer metric for insulin resistance. Insulin resistance occurs when cells in muscles, fat and the liver don’t respond well to insulin and can’t use glucose.

Insulin 52
Insulin Cardiology Research Doctors 52
article thumbnail

Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction

The Pharma Data

JULY 8, 2021

Full results from the EMPEROR-Preserved trial are scheduled for presentation at the European Society of Cardiology (ESC) Congress 2021 on August 27. Low blood sugar (hypoglycemia): If you take JARDIANCE with another medicine that can cause low blood sugar, such as sulfonylurea or insulin, your risk of low blood sugar is higher.

Trials 52
Trials Doctors Doctor Medicine 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024